All Access Articles |
- Corcept Therapeutics Submits NDA for Relacorilant in Ovarian Cancer | 2025-07-15 | PHARMACEUTICAL
- Corcept Therapeutics Submits NDA for Ovarian Cancer Drug | 2025-07-14 | PHARMACEUTICAL
- Understanding Corcept Therapeutics – A Fundamental Overview | 2025-04-18 | PHARMACEUTICAL
- Analyzing CORT Stock's Decline and Valuation Insights | 2025-02-20 | PHARMACEUTICAL
- Investors Brace for Market Moves After CORT Loses Out in Court | 2024-01-02 | PHARMACEUTICAL